Toxoplasmosis – A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries
Open accessThe DOI matches its Crossref record; 370 of the 372 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Toxoplasmosis is becoming a global health hazard as it infects 30-50% of the world human population. Clinically, the life-long presence of the parasite in tissues of a majority of infected individuals is usually considered asymptomatic. However, a number of studies show that this 'asymptomatic infection' may also lead to development of other human pathologies. AIMS OF THE STUDY: The purpose of the study was to collect available geoepidemiological data on seroprevalence of toxoplasmosis and search for its relationship with mortality and disability rates in different countries. METHODS AND FINDINGS: Prevalence data published between 1995-2008 for women in child-bearing age were collected for 88 countries (29 European). The association between prevalence of toxoplasmosis and specific disease burden estimated with age-standardized Disability Adjusted Life Year (DALY) or with mortality, was calculated using General Linear Method with Gross Domestic Product per capita (GDP), geolatitude and humidity as covariates, and also using nonparametric partial Kendall correlation test with GDP as a covariate. The prevalence of toxoplasmosis correlated with specific disease burden in particular countries explaining 23% of variability in disease burden in Europe. The analyses revealed that for example, DALY of 23 of 128 analyzed diseases and disease categories on the WHO list showed correlations (18 positive, 5 negative) with prevalence of toxoplasmosis and another 12 diseases showed positive trends (p<0.1). For several obtained significant correlations between the seroprevalence of toxoplasmosis and specific diseases/clinical entities, possible pathophysiological, biochemical and molecular explanations are presented. CONCLUSIONS: The seroprevalence of toxoplasmosis correlated with various disease burden. Statistical associations does not necessarily mean causality. The precautionary principle suggests however that possible role of toxoplasmosis as a triggering factor responsible for development of several clinical entities deserves much more attention and financial support both in everyday medical practice and future clinical research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Current evidence suggests that foodborne parasites are important causes of disease.”
From Food Safety in Low and Middle Income Countries (2015) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“worldwide more than one in three people are infected with toxoplasmosis [24] and one in ten with giardiasis [25] (not all these infections are symptomatic).”
From Food Safety in Low and Middle Income Countries (2015) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tabachnick, B. G., & Fidell, L. S. (1983) · Cited by 80,042
Nonparametric Statistics for the Behavioral Sciences
Guitton, H., & Siegel, S. (1958) · Revue économique · doi:10.2307/3498751 · Cited by 35,245
Foodborne illness acquired in the United States—Major pathogens
Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M.-A., Roy, S. L., Jones, J. L., & Griffin, P. M. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.p11101 · Cited by 7,657 · cited 1×
“Nevertheless, toxoplasmosis is one of the leading causes of death attributed to foodborne illness [7].”
BackgroundFood-Related Illness and Death in the United States
Mead, P. S., Slutsker, L., Dietz, V., McCaig, L. F., Bresee, J. S., Shapiro, C., Griffin, P. M., & Tauxe, R. V. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0505.990502 · Cited by 7,235
Higgins, S. M. F., Macken, A. P., Cullen, W., Saunders, J., Dunne, C. P., & O’Gorman, C. S. (2013) · PubMed · doi:10.34961/9953 · Cited by 4,806
Toxoplasma gondii: from animals to humans
Tenter, A. M., Heckeroth, A. R., & Weiss, L. M. (2000) · International Journal for Parasitology · doi:10.1016/s0020-7519(00)00124-7 · Cited by 3,702
Montoya, J., & Liesenfeld, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16412-x · Cited by 3,232
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Global Burden of Disease and Risk Factors
(2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,605
Toxoplasmosis of Animals and Humans
Dubey, J. P. (2016) · CRC Press eBooks · doi:10.1201/9781420092370 · Cited by 2,071
Research works printed but not linked: 21
- C Nicolle, 1908, Sur une infection à corps de Leishman (ou organismes voisins) du gondi, C R Acad Sci (Paris), 147, 763
- Pawłowski Z (1994) Toxoplasmosis. In: Januszkiewicz J, editor. The outline of infectious diseases in the clinic. 2nd ed. Warsaw: PZWL. pp. 214–218.
- M Makuwa, 1992, Toxoplasmose et al femme enceinte au Congo Bilan de 5 ans de dépistage (1986–1990), Med Afr Noire, 39, 493
- T Ancelle, 2003, La toxoplasmose en France chez la femme enceinte en 2003: séroprévalence et facteurs associés, Bull Epidemiol Hebd, 51, 227
- NK Mahdi, 2002, Risk factors for acquiring toxoplasmosis in pregnancy, J Bahrain Med Soc, 14, 148
- J Iqbal, 2003, Toxoplasmosis in Kuwait: improved diagnosis based on quantitative immuno-assay, Clin Microbiol Infect, 9, 336
- L Rockiene, 1997, The prognosis of congenital toxoplasmosis in Lithuania, Hygiena Epidemiol, 58, 39
- MU Ahmed, 1997, Toxoplasmosis and abortion: serological correlation, J Coll Phys Surg Pak, 7, 156
- M Deniau, 1991, Évaluation des risques de toxoplasmose congénitale au Togo, Bull Soc Pathol Exot Filial, 84, 664
- T Ndong-Obame, 1997, La toxoplasmose acquise et congénitale dans la région de Sfax (Tunisie), Bull Soc Fr Parasitol, 15, 141
- M Triolo-Mieses, 2006, Serological prevalence of Toxoplasma gondii antibodies in pregnancy in Palavecino Municipality Lara State,Venezuela, Kasmera, 34, 7
- P Kodym, 2000, Toxoplasma in the Czech Republic 1923–1999: first case to widespread outbreak, Int J Parasitol, 30, 11
- VJ Ling, 2011, Toxoplasma gondii seropositivity and completed suicide in 20 European countries, Biol Psychiatry, 69, 500
- OY Kusbeci, 2011, Could Toxoplasma gondii have any role in Alzheimer disease?, Alzheimer Dis Assoc Disord, 25, 1, 10.1097/wad.0b013e3181f73bc2 · DOI · Paper page
- GM Andrade, 2008, Hearing loss in congenital toxoplasmosis detected by newborn screening, Braz J Otorhinolaryngol, 74, 21, 10.1016/s1808-8694(15)30746-1 · doi:10.1016/s1808-8694(15)30746-1
- G Fond, 2013, Toxoplasma gondii: a potential role in the genesis of psychiatric disorders, Encephale, 39, 38
- L Hostomská, 1957, The role of toxoplasmosis in the mother in the development of mongolism in the child (in Czech), Českosl Pediatr, 12, 713
- S Slosarkova, 1999, Toxoplasmosis and iodine deficiency in Angora goats, Vet Parasitol, 81, 89, 10.1016/s0304-4017(98)00244-1 · DOI
- Prandota J (2012) Rhesus-associated glycoprotein (RhAG) phenotype of the red blood cells modulates T. gondii infection-associated psychomotor performance reaction times and changes in the human personality profile. Impaired function of the CO2, AQP1, and AQP4 gas channels may cause hypoxia and thus enhance neuroinflammation in autistic individuals. In: Gemma C, editor. Neuroinflammation: Pathogenesis, Mechanisms and Management. New York: Nova Publishers. pp. 423–439.
- D Hippe, 2006, Toxoplasma gondii inhibits host cell apoptosis triggered by both intrinsic and extrinsic proapoptotic signals, Int J Med Microbiol, 296, 105
- Prandota J (2012) Increased generation of antibodies and autoantibodies directed against brain proteins in patients with autism and their families may be caused by T. gondii infection. Maternal and fetal microchimerisms probably play an important role in these processes acting as a “Trojan horse” in dissemination of the parasite. In: Gemma C, editor. Neuroinflammation Pathogenesis, Mechanisms, and Management. New York: Nova Publishers. pp. 447–638.
Cited by
Items 201–300 of 807
A Toxoplasma gondii patatin-like phospholipase contributes to host cell invasion
Wilson, S. K., Heckendorn, J., Genova, B. M. D., Koch, L. L., Rooney, P. J., Morrissette, N. S., Lebrun, M., & Knoll, L. J. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008650 · Cited by 23
Lass, A., Kontogeorgos, I., Ma, L., Zhang, X., Li, X., & Karanis, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-09166-0 · Cited by 23
El-Shqanqery, H. E., Ibrahim, H. M., Mohamed, A. H., & El-Sharaawy, A. A. (2017) · Journal of the Egyptian Society of Parasitology · doi:10.21608/jesp.2017.77989 · Cited by 23
Sutterland, A. L., Mounir, D. A., Ribbens, J. J., Kuiper, B., van Gool, T., & de Haan, L. (2020) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaa042 · Cited by 22
Inflammasome Activation Dampens Type I IFN Signaling to Strengthen Anti- Toxoplasma Immunity
Hu, Z., Wu, D., Lu, J., Zhang, Y., Yu, S.-M., Xie, Y., Li, H., Yang, J., Lai, D., Zeng, K., et al. (2022) · mBio · doi:10.1128/mbio.02361-22 · Cited by 22
Zhou, Z., Zhou, R., Li, K., Wei, W., Zhang, Z., Zhu, Y., & Luan, R. (2019) · BioMed Research International · doi:10.1155/2019/8186017 · Cited by 22
Borkowski, P. K., Brydak-Godowska, J. E., Wojciech, B., Karolina, Ś., Hanna, Ż.-P., Maria, O.-K., Piotr, K., & Rabczenko, D. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004892 · Cited by 22
Lerner, D. A., Alkærsig, L., Fitza, M., Lomberg, C., & Johnson, S. K. (2020) · Entrepreneurship Theory and Practice · doi:10.1177/1042258719890992 · Cited by 22
Imam, A. M., Al‐Anzi, F., Al-Ghasham, M. A., Alsuraikh, M. A., Al-Yahya, A. O., & Rasheed, Z. (2017) · Saudi Medical Journal · doi:10.15537/smj.2017.3.18535 · Cited by 22
Odeniran, P. O., Ademola, I. O., & Jegede, H. O. (2018) · Parasitology Research · doi:10.1007/s00436-018-5958-8 · Cited by 22
The Level of Knowledge about Toxoplasmosis among University Students in Rabat in Morocco
Hamou, S. A., Lamhamdi, B., Hayah, I., Belbacha, I., Sadak, A., & Laboudi, M. (2021) · Journal of Parasitology Research · doi:10.1155/2021/5553977 · Cited by 22
da Costa, A., Zorgi, N. E., do Nascimento, N., Galisteo, A. J., & de Andrade, H. F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.155 · Cited by 22
Current control options and a way towards risk-based control of Toxoplasma gondii in the meat chain
Kuruca, L., Belluco, S., Vieira-Pinto, M., Antic, D., & Blagojevic, B. (2023) · Food Control · doi:10.1016/j.foodcont.2022.109556 · Cited by 21
The Function of Membrane Integral Pyrophosphatases From Whole Organism to Single Molecule
Holmes, A. O. M., Kalli, A. C., & Goldman, A. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00132 · Cited by 21
Jaroš, F. (2018) · Biosemiotics · doi:10.1007/s12304-018-9332-0 · Cited by 21
Flegr, J., & Dama, M. S. (2014) · Folia Parasitologica · doi:10.14411/fp.2014.061 · Cited by 21
Self-citationMartynowicz, J., Doggett, J. S., & Sullivan, W. J. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00539-20 · Cited by 21
Sena, F., Cancela, S., Bollati‐Fogolín, M., Pagotto, R., & Francia, M. E. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1134471 · Cited by 20
Păunescu, E., Boubaker, G., Desiatkina, O., Anghel, N., Amdouni, Y., Hemphill, A. F., & Furrer, J. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113610 · Cited by 20
Bentum, K. E., Folitse, R. D., Amemor, E., Burimuah, V., Opoku-Agyemang, T., & Emikpe, B. O. (2019) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2019.1642916 · Cited by 20
Prandota, J., Elleboudy, N. A. F., Ismail, K. A., Zaki, O. K., & Shehata, H. H. (2015) · International Journal of Neurology Research · doi:10.17554/j.issn.2313-5611.2015.01.30 · Cited by 20
Self-citationShiadeh, M. N., Esfandyari, S., Ashrafmansouri, M., Mirzapour, A., Taghipour, A., Spotin, A., Arefkhah, N., Gamble, R., Safa, A., & Rostami, A. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104549 · Cited by 20
Snijders, G. J. L., van Mierlo, H. C., Boks, M. P., Begemann, M., Sutterland, A. L., Litjens, M., Ophoff, R. A., Kahn, R. S., & de Witte, L. D. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0636-x · Cited by 20
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
Koger-Pease, C., Perera, D. J., & Ndao, M. (2023) · Pharmaceuticals · doi:10.3390/ph16030334 · Cited by 20
Anas, M., Kumari, V., Gupta, N., Dube, A., & Kumar, N. (2019) · Cell Stress and Chaperones · doi:10.1007/s12192-019-01016-9 · Cited by 20
Belk, K. W., Connolly, M. P., Schlesinger, L., & Ben-Harari, R. R. (2018) · Pathogens and Global Health · doi:10.1080/20477724.2018.1552644 · Cited by 20
Inhibition of Toxoplasma gondii Growth by Dihydroquinine and Its Mechanisms of Action
Huffman, A. M., Ayariga, J. A., Napier, A., Robertson, B. K., & Abugri, D. A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.852889 · Cited by 20
Moghimi, M., Doosti, M., Vahedian-Ardakani, H., Talebi, A., Ghalibaf, M. A., Najafi, A., Aminorroaya, M. M., Yazdani, S., Shayestehpour, M., Bahrami, H., et al. (2015) · PubMed Central · Cited by 20
Controlling infection in predator-prey systems with transmission dynamics
Cojocaru, M. G., Migot, T., & Jaber, A. (2019) · Infectious Disease Modelling · doi:10.1016/j.idm.2019.12.002 · Cited by 20
Novel Toxoplasma gondii inhibitor chemotypes
Sanford, A. G., Schulze, T. T., Potluri, L., Hemsley, R. M., Larson, J. J., Judge, A. K., Zach, S. J., Wang, X., Charman, S. A., Vennerstrom, J. L., et al. (2018) · Parasitology International · doi:10.1016/j.parint.2017.10.010 · Cited by 20
Anti-Toxoplasma gondii effect of two spider venoms in vitro and in vivo
Hou, S., Liu, Y., Tang, Y., Wu, M., Guan, J., Li, X., Wang, Z., Jiang, J., Deng, M., Duan, Z., et al. (2019) · Toxicon · doi:10.1016/j.toxicon.2019.05.003 · Cited by 20
No Evidence of Association between Toxoplasma gondii Infection and Financial Risk Taking in Females
Lanchava, L., Carlson, K., Šebánková, B., Flegr, J., & Nave, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136716 · Cited by 19
Self-citationAlvarado‐Esquivel, C., Carrillo-Oropeza, D., Pacheco-Vega, S. J., Hernández‐Tinoco, J., Salcedo-Jáquez, M., Sánchez-Anguiano, L. F., Ortiz-Jurado, M. N., Alarcón-Alvarado, Y., Liesenfeld, O., & Beristáin-García, I. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0912-1 · Cited by 19
Brito, R. M. D. M., da Silva, M. C. M., Vieira-Santos, F., Lopes, C. D. A., Souza, J. L. N., Bastilho, A. L., Fernandes, H. D. B., de Miranda, A. S., de Oliveira, A. C. P., Vítor, R. W. A., et al. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100652 · Cited by 19
dos Santos, B. R., Ramos, A. B. D. S. B., de Menezes, R. P. B., Scotti, L., Colombo, F. A., Marques, M. J., & Reimão, J. Q. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288335 · Cited by 19
Thái, T. L., Jun, H., Park, S.-H., Lê, H. G., Lee, J., Ahn, S. K., Kang, J., Myint, M. K., Lin, K., Sohn, W., et al. (2019) · Korean Journal of Parasitology · doi:10.3347/kjp.2019.57.3.303 · Cited by 19
Gasdermins in Innate Host Defense Against Entamoeba histolytica and Other Protozoan Parasites
Wang, S., Moreau, F., & Chadee, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900553 · Cited by 18
Latifi, A., & Flegr, J. (2025) · Biomedicines · doi:10.3390/biomedicines13071731 · Cited by 18
Self-citationReichert, M. S., Bolek, M. G., & McCullagh, E. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300186120 · Cited by 18
Han, Y., Nie, L., Ye, X., Zhou, Z., Huang, S., Zeng, C., Guo, C., Ou, M., Xiao, D., Zhang, B., et al. (2018) · Parasitology Research · doi:10.1007/s00436-017-5737-y · Cited by 18
CRISPR/Cas12a combined with RPA for detection of T. gondii in mouse whole blood
Wang, X., Cheng, M., Yang, S., Chen, X., Li, Q., Zhu, Y., Ji, Y., & Du, Y. (2023) · Parasites & Vectors · doi:10.1186/s13071-023-05868-0 · Cited by 18
Eid, R. K., Arafa, M. F., Ashour, D. S., Essa, E. A., El-Wakil, E. S., Younis, S. S., & Maghraby, G. M. E. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122912 · Cited by 18
Stadler, R. V., Nelson, S. R., Warshaw, D. M., & Ward, G. E. (2022) · eLife · doi:10.7554/elife.85171 · Cited by 18
Pazoki, H., Ziaee, M., Anvari, D., Rezaei, F., Ahmadpour, E., Haghparast-Kenari, B., Saljoghi, F., Biderouni, F. T., Barac, A. M., & Pagheh, A. S. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104578 · Cited by 18
The association between Toxoplasma infection and mortality: the NHANES epidemiologic follow-up study
Huang, J., Zheng, J., Liu, B., Lu, L., Wu, H., Lin, S., & Li, D. (2022) · Parasites & Vectors · doi:10.1186/s13071-022-05398-1 · Cited by 18
Interaction of apigenin-7-O-glucoside with pyrimethamine against Toxoplasma gondii growth
Abugri, D. A., & Witola, W. H. (2019) · Journal of Parasitic Diseases · doi:10.1007/s12639-019-01185-5 · Cited by 18
Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 Signaling
Hamie, M., Najm, R., Deleuze‐Masquéfa, C., Bonnet, P., Dubremetz, J., El-Sabban, M. E., & Hajj, H. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629917 · Cited by 18
Kumari, P., Eo, K.-Y., Lee, W.-S., Kimura, J., & Yamamoto, N. (2021) · Journal of Veterinary Medical Science · doi:10.1292/jvms.20-0596 · Cited by 18
Hlaváčová, J., Flegr, J., Fiurašková, K., & Kaňková, Š. (2021) · Pathogens · doi:10.3390/pathogens10081052 · Cited by 18
Self-citationKim, M.-J., Lee, S., Kang, H., Chu, K., Park, H., Jin, H., Moon, E., Kim, S. S., & Quan, F. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104090 · Cited by 17
Wu, Q., Zhang, Z., Chu, H., Xia, B., Li, W., Ding, J., Ding, H., Zheng, B., Gao, M. Q., Wang, Y., et al. (2025) · Infectious Diseases of Poverty · doi:10.1186/s40249-025-01332-6 · Cited by 17
Carrillo, G. L., Su, J., Cawley, M. L., Wei, D., Gill, S. K., Blader, I. J., & Fox, M. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15770 · Cited by 17
Nayeri, T., Sarvi, S., Moosazadeh, M., Hosseininejad, Z., Amouei, A., & Daryani, A. (2020) · Pathogens and Global Health · doi:10.1080/20477724.2020.1738153 · Cited by 17
Toxoplasma gondii infection and testosterone alteration: A systematic review and meta-analyses
Abdoli, A., Ghaffarifar, F., Sharifi, Z., & Taghipour, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297362 · Cited by 17
High resistance to Toxoplasma gondii infection in inducible nitric oxide synthase knockout rats
Wang, Z.-J., Yu, S.-M., Gao, J.-M., Zhang, P., Hide, G., Yamamoto, M., Lai, D., & Lun, Z. (2021) · iScience · doi:10.1016/j.isci.2021.103280 · Cited by 17
Delayed IL-12 production by macrophages during Toxoplasma gondii infection is regulated by miR-187
Jiang, H., Zhai, T., Yu, Y., Li, X., Gong, P., Zhang, X., Li, G., & Li, J. (2020) · Parasitology Research · doi:10.1007/s00436-019-06588-0 · Cited by 17
Toxoplasmosis Immunity Status of Blood Donors in Sidi Bel Abbès, West Algeria
Belkacemi, M., & Heddi, B. (2022) · Cureus · doi:10.7759/cureus.28826 · Cited by 17
Protective immunity induced by TgMIC5 and TgMIC16 DNA vaccines against toxoplasmosis
Zhu, Y.-C., Ma, L.-J., Zhang, J.-L., Liu, J.-F., He, Y., Feng, J.-Y., & Chen, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.686004 · Cited by 16
Flegr, J., Šebánková, B., Příplatová, L., Chvátalová, V., & Kaňková, Š. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200346 · Cited by 16
Self-citationCSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondii
Lykins, J. D., V, Filippova, E. V., Halavaty, A. S., Minasov, G., Zhou, Y., Dubrovska, I., Flores, K. J., Shuvalova, L., Ruan, J., Bissati, K. E., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00352 · Cited by 16
Toxoplasma gondii And Neospora caninum In Brain Tissue Of Rodents In North-West Iran
Nazari, N., Shojaee, S., Mohebali, M., Teimouri, A., Ghadiri, K., Raeghi, S., Shiee, M. R., Azarakhsh, Y., & Bozorgomid, A. (2019) · Veterinary Medicine Research and Reports · doi:10.2147/vmrr.s224664 · Cited by 16
Drug Resistance Assays for Parasitic Diseases
Légaré, D., & Ouellette, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_36 · Cited by 16
From conifers to cognition: Microbes, brain and behavior
Lathe, R., & Clair, D. S. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12680 · Cited by 16
A Family of Toxoplasma gondii Genes Related to GRA12 Regulate Cyst Burdens and Cyst Reactivation
Guevara, R. B., Fox, B. A., & Bzik, D. J. (2021) · mSphere · doi:10.1128/msphere.00182-21 · Cited by 16
Gan, X., Zhang, X., Cheng, Z., Chen, L., Ding, X., Du, J., Cai, Y., Luo, Q., Shen, J., Wang, Y., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.076 · Cited by 16
In vitro Effect of Harmine Alkaloid and Its N-Methyl Derivatives Against Toxoplasma gondii
Alomar, M. L., Yañuk, J. G., Angel, S. O., Gonzalez, M. M., & Cabrerizo, F. M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.716534 · Cited by 16
Anti-Toxoplasma gondii activity of Trametes versicolor (Turkey tail) mushroom extract
Sharma, H. N., Catrett, J., Nwokeocha, O. D., Boersma, M., Miller, M. E., Napier, A., Robertson, B. K., & Abugri, D. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-35676-6 · Cited by 16
SEROPREVALENCE AND RISK FACTORS FOR HUMAN TOXOPLASMOSIS IN NORTHEASTERN BRAZIL
Aloise, D. D. A., Coura‐Vital, W., Carneiro, M., Rodrigues, M. V., Toscano, G. A. D. S., da Silva, R. B., de Andrade‐Neto, V. F., & Vítor, R. W. A. (2018) · Revista de Patologia Tropical / Journal of Tropical Pathology · doi:10.5216/rpt.v46i4.51013 · Cited by 16
Role of inflammasomes in innate host defense against Entamoeba histolytica
Begum, S., Gorman, H., Chadha, A., & Chadee, K. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0420-465r · Cited by 15
A Review of Immunological and Neuropsychobehavioral Effects of Latent Toxoplasmosis on Humans
Arababadi, M. K., Abdollahi, S. H., Ramezani, M., & Zare‐Bidaki, M. (2024) · Parasite Immunology · doi:10.1111/pim.13060 · Cited by 15
Toxoplasmosis in pregnancy: a neglected bane but a serious threat in Nigeria
Oyeyemi, O. T., Oyeyemi, I. T., Adesina, I. A., Tiamiyu, A. M., Oluwafemi, Y. D., Nwuba, R. I., & Grenfell, R. F. Q. (2019) · Parasitology · doi:10.1017/s0031182019001525 · Cited by 15
Sint, N. H., Htun, Y. M., Win, T. T., Mon, A. S., Lwin, T. Z., Maung, L. O., Win, P. S., Naing, K. M., Zaw, T. P., Naing, P. H., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284352 · Cited by 15
Toxoplasma gondii Infection and Threatened Abortion in Women from Northern Peru
Valladares-Garrido, M. J., Failoc‐Rojas, V. E., Peralta, C. I., Astudillo-Rueda, D., & Silva-Díaz, H. (2022) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2022/1163655 · Cited by 15
Parasitic Manipulations of the Host Phenotype: Effects in Internal and External Environments
Gopko, M., & Mikheev, V. N. (2019) · Biology Bulletin Reviews · doi:10.1134/s2079086419010018 · Cited by 15
Duffy, A., O’Connell, J. R., Pavlovich, M. A., Ryan, K. A., Lowry, C. A., Daue, M., Raheja, U. K., Brenner, L. A., Markon, A. O., Punzalan, C., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193732 · Cited by 15
Inferring the Ecological Niche of Toxoplasma gondii and Bartonella spp. in Wild Felids
Escobar, L. E., Carver, S., Romero-Álvarez, D., VandeWoude, S., Crooks, K. R., Lappin, M. R., & Craft, M. E. (2017) · Frontiers in Veterinary Science · doi:10.3389/fvets.2017.00172 · Cited by 15
Flegr, J., Hlaváčová, J., & Toman, J. (2023) · Folia Parasitologica · doi:10.14411/fp.2023.020 · Cited by 15
Self-citationNazari, N., Shojaee, S., Salimi, M., Mohebali, M., Ahmadifard, N., Hamzavi, Y., Zarei, Z., Farahmand-Rad, R., Bozorgomid, A., & Heydarian, P. (2020) · Iranian Journal of Parasitology · doi:10.18502/ijpa.v15i2.3308 · Cited by 15
Okojokwu, O. J., Nwachukwu, E., Ali, M. A., & Agabi, Y. A. (2022) · Microbes and Infectious Diseases /Microbes and Infectious Diseases · doi:10.21608/mid.2022.126484.1258 · Cited by 14
Kiani, B., Rahmati, A. R., Bergquist, R. N., & Moghaddas, E. (2020) · The International Journal of Health Planning and Management · doi:10.1002/hpm.3010 · Cited by 14
dos Santos, D. A., Souza, H. F. S., Silber, A. M., de Souza, T. D. A. C. B., & Ávila, A. R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1175409 · Cited by 14
Alves, E., Benns, H. J., Magnus, L., Dominicus, C. S., Dobai, T., Blight, J., Wincott, C. J., & Child, M. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.728425 · Cited by 14
Šagud, M., Vlatković, S., Štrac, D. Š., Sviben, M., Živković, M., Vilibić, M., Vuksan‐Ćusa, B., Mihaljević-Peleš, A., & Pivac, N. (2018) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2018.02.002 · Cited by 14
Moglad, E. H. O., Elekhnawy, E., Negm, W. A., Eliwa, D., Younis, S. S., Elmansory, B. M., Mahgoub, S., Ahmed, E., & Al-Fakhrany, O. M. (2023) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2023.2215531 · Cited by 14
Babaie, J., Sayyah, M., Gharagozli, K., Mostafavi, E., & Golkar, M. (2017) · EXCLI journal · doi:10.17179/excli2016-858 · Cited by 14
Latent toxoplasmosis and olfactory functions of Rh positive and Rh negative subjects
Flegr, J., Milinski, M., Kaňková, Š., Hůla, M., Hlaváčová, J., & Sýkorová, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209773 · Cited by 14
Self-citationDeka, S., Kalita, D., Gupta, P., & Mathuria, Y. P. (2021) · Nepal Journal of Epidemiology · doi:10.3126/nje.v11i1.34228 · Cited by 14
Untargeted Metabolomics Uncovers the Essential Lysine Transporter in Toxoplasma gondii
Kloehn, J., Lunghi, M., Varesio, E., Dubois, D. J., & Soldati‐Favre, D. (2021) · Metabolites · doi:10.3390/metabo11080476 · Cited by 14
The effects of toxoplasmosis on sex ratio at birth
Flegr, J., & Kaňková, Š. (2019) · Early Human Development · doi:10.1016/j.earlhumdev.2019.104874 · Cited by 14
Self-citationŠebánková, B., & Flegr, J. (2017) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2017.00144 · Cited by 13
Self-citationActivity-Based Protein Profiling for the Study of Parasite Biology
Benns, H. J., Tate, E. W., & Child, M. A. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_123 · Cited by 13
Thakur, R., Sharma, R., Aulakh, R. S., Gill, J. P. S., & Singh, B. B. (2021) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2021.101739 · Cited by 13
The Clean India Mission: Public and animal health benefits
Thakur, R., Singh, B. B., Jindal, P., Aulakh, R. S., & Gill, J. P. S. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.06.024 · Cited by 13
Toxoplasmosis in man and animals
Abdel-Rahman, A. M. (2017) · Egyptian Journal of Chemistry and Environmental Health · doi:10.21608/ejceh.2017.245783 · Cited by 13
Asgari, Q., Mohammadpour, I., Pirzad, R., Kalantari, M., Motazedian, M. H., & Naderi, S. (2018) · PubMed Central · Cited by 13
Role of inflammasomes in Toxoplasma and Plasmodium infections
Wang, Z., Jiao, W.-J., Yang, Y., Liu, H.-L., & Wang, H.-L. (2024) · Parasites & Vectors · doi:10.1186/s13071-024-06529-6 · Cited by 13
Daka, V., Mukosha, M., Matafwali, S. K., Mudenda, S., & Phiri, A. M. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002235 · Cited by 13
Ocular Toxoplasmosis: Mechanisms of Retinal Infection and Experimental Models
Fernandez, V. R., Casini, G., & Bruschi, F. (2021) · Parasitologia · doi:10.3390/parasitologia1020007 · Cited by 13
Aerts, R., Mercier, T., Beckers, M., Schoemans, H. M., Lagrou, K., & Maertens, J. A. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.033 · Cited by 13
Rosypal, A. C., Houk, A. E., Zajac, A. M., & Lindsay, D. S. (2015) · Zoonoses and Public Health · doi:10.1111/zph.12184 · Cited by 13
Metadata
- Authors
- Flegr, J., Prandota, J., Sovičková, M., & Israili, Z. H.
- Affiliations
- Wroclaw Medical University (PL)
- Charles University (CZ)
- Emory University (US)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-24
- Volume
- 9
- Issue
- 3
- Pages
- e90203
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3963851
- OpenAlex
- W2131025240
- Cited by
- 700
- References
- 372
- Citations by year
- 2026: 32 · 2025: 45 · 2024: 58 · 2023: 68 · 2022: 76 · 2021: 89 · 2020: 81 · 2019: 64 · 2018: 54 · 2017: 56 · 2016: 34 · 2015: 33 · 2014: 9
- FWCI
- 32.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Univerzita Karlova v Praze (UNCE 204004)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Toxoplasma gondii Research Studies
- Life Sciences › Immunology and Microbiology › Parasitology › Parasitic infections in humans and animals
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Keywords
- toxoplasmosis, latent toxoplasmosis, seroprevalence, disease burden, disability-adjusted life years, mortality, women of child-bearing age, global health, cross-national comparison, gross domestic product, humidity, asymptomatic infection
- MeSH terms
- Accidents, Traffic, Female, Geography, Humans, Humidity, Male, Suicide, Toxoplasmosis, Prevalence, Seroepidemiologic Studies, Quality-Adjusted Life Years, Internationality, Asymptomatic Diseases, Gross Domestic Product
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.